Practical implication
Organizations must establish an active EMA user account, ensure they have a valid EMA customer account number, and complete the SPOR/OMS registration process within five to ten working days if not previously registered.
Registration in the IRIS system is now a prerequisite for all pharmacovigilance and safety-related submissions in the EU, effective from June 15, 2026. Proper management of RPIs is critical for maintaining data integrity across pharmacovigilance databases.
What changed: The guide specifies that all submissions related to pharmacovigilance and safety in the EU must utilize the IRIS system for registration, with the requirement to request a new Research Product Identifier (RPI) if not already associated with an existing one.
Why it matters: Accurate registration and management of RPIs are essential for compliance with EU pharmacovigilance regulations, ensuring that organizations can effectively engage in safety monitoring and regulatory submissions.
Practical implication: Organizations must establish an active EMA user account, ensure they have a valid EMA customer account number, and complete the SPOR/OMS registration process within five to ten working days if not previously registered.
View original source
Published from the Firecrawl policy change extraction pipeline.